First-in-human, phase 1, open-label, dose-escalation, dose-expansion study of ADCT-901 as monotherapy in patients with select advanced solid tumors.

Harvey, R. Donald, Falchook, Gerald Steven, Naqash, Abdul Rafeh · Journal of Clinical Oncology · 2022